Balance sheet of Indo US Bio-Tech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Indo US Bio-Tech is increasing.
Latest debt of Indo US Bio-Tech is ₹12.13 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹11.23 Crs.

Yes, profit is increasing.
The profit of Indo US Bio-Tech is ₹13.11 Crs for TTM, ₹8.25 Crs for Mar 2024 and ₹7.24 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indo US Bio-Tech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory